Enhanced Knowledge Articles

Glucagon-like peptide-1 (GLP-1) receptor agonists have rapidly emerged as one of the most influential pharmaceutical classes in modern metabolic medicine. Initially developed for glycemic control in type 2 diabetes, these agents now demonstrate profound effects on...

Welcome to 2026! CES (Las Vegas, January 2026) is no longer just TVs and laptops. This year’s health-and-longevity wave is loud and clear: more home biomarkers, more “physiological age” scoring, more non-invasive sensing, and more subscription services layered on top...

Turning 50 changes the rules of health. Muscle loss accelerates, cardiovascular risk rises, sleep becomes more fragile, and cognitive resilience depends increasingly on lifestyle. The good news: modern longevity science is clear. A small set of high-confidence...

October 04, 2025 (America/Los_Angeles) Brought to you by the Longevity Academy Executive Summary The most significant signal in the last 24 hours is the publication of a human randomized controlled trial in Cell Reports Medicine demonstrating that the diabetes drug...